Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells

Clinical trial NCT05925608 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05925608
Sponsor: BioCardia, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Heart Failure, Systolic

Start date: 2023-08-23
Primary completion: 2026-12-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.